Cargando…
Histone Deacetylase Inhibitors in the Treatment of Hepatocellular Carcinoma: Current Evidence and Future Opportunities
Hepatocellular carcinoma (HCC) remains a major health problem worldwide with a continuous increasing prevalence. Despite the introduction of targeted therapies like the multi-kinase inhibitor sorafenib, treatment outcomes are not encouraging. The prognosis of advanced HCC is still dismal, underlying...
Autores principales: | Garmpis, Nikolaos, Damaskos, Christos, Garmpi, Anna, Georgakopoulou, Vasiliki E., Sarantis, Panagiotis, Antoniou, Efstathios A., Karamouzis, Michalis V., Nonni, Afroditi, Schizas, Dimitrios, Diamantis, Evangelos, Koustas, Evangelos, Farmaki, Paraskevi, Syllaios, Athanasios, Patsouras, Alexandros, Kontzoglou, Konstantinos, Trakas, Nikolaos, Dimitroulis, Dimitrios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004277/ https://www.ncbi.nlm.nih.gov/pubmed/33809844 http://dx.doi.org/10.3390/jpm11030223 |
Ejemplares similares
-
Investigational Drug Treatments for Triple-Negative Breast Cancer
por: Damaskos, Christos, et al.
Publicado: (2021) -
Clinical Significance of the Histone Deacetylase 2 (HDAC-2) Expression in Human Breast Cancer
por: Garmpis, Nikolaos, et al.
Publicado: (2022) -
COVID-19: do it like Greece. Why Greece is coping with COVID-19 better than other countries?
por: Damaskos, Christos, et al.
Publicado: (2020) -
The Emerging Role of Histone Deacetylase Inhibitors in Cervical Cancer Therapy
por: Psilopatis, Iason, et al.
Publicado: (2023) -
The Role of SNHG15 in the Pathogenesis of Hepatocellular Carcinoma
por: Damaskos, Christos, et al.
Publicado: (2022)